The effect oral methadone on improvement dyspnea in patients with Covid-19
Not Applicable
Recruiting
- Conditions
- COVID-19.Use this code when COVID-19 has been confirmed by laboratory testing irrespective of severity of clinical signs or symptoms. Use additional code, if desired, to identify pneumonia or other manifestations.B34.2
- Registration Number
- IRCT20210820052236N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Patient admitted to covid-19 wards of Sabzevar Vasei Hospital,
Positive PCR test result
Willingness to cooperate (written consent)
Phase 2 of Covid disease -19 (moderate or severe)
Exclusion Criteria
Cigarette and drug addiction
History of drug use or methadone therapy
Liver failure
Breastfeeding and pregnant women
Pulmonary insufficiency
Kidney failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of respiration is measured quantitatively by improving the percentage of peripheral blood oxygen, which is measured by pulse oximetry, and qualitatively by increasing the score of the vas and borg questionnaires. Timepoint: Daily at a specific time (12 noon) for up to 4 days. Method of measurement: Percentage of peripheral blood oxygen with pulse oximetry. Respiratory quality with vas and borg questionnaires.
- Secondary Outcome Measures
Name Time Method